Brought to you by 
Pain treatment start-up Solace takes in $15mm via Series A
02 May 2007
Executive Summary
Pain medicines developer Solace Pharmaceuticals has raised $15mm in its Series A financing, which was co-led by new investors Polaris Venture Partners and InterWest Partners and included seed financier PureTech Ventures. Members of Polaris and InterWest joined the company's board.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pain treatment start-up Solace takes in $15mm via Series A
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice